COMMUNIQUÉS West-GlobeNewswire

Parents in Distress: New Survey Highlights the Impact of Lost Sleep on Busy Parents
24/09/2026
Aeroflow Sleep’s new survey found that just 5% of parents are getting the recommended amount of sleep, and 86% of parents want their healthcare providers to share resources to overcome sleep challenges ASHEVILLE, N.C., [...]
Medevise Consulting to Host “Robotics in Ophthalmology” Workshop in New Orleans During AAO 2026
24/09/2026
Regulatory, reimbursement, and surgical robotics leaders will ask what it takes for robots to leapfrog today’s standard of care in eye surgery NEW ORLEANS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Medevise Consulting today [...]
Persevere Therapeutics Announces Treatment of First Patient in its MIROC-1 Phase 2a Ovarian Cancer Clinical Trial
24/09/2026
CHESTERBROOK, PA, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc., a clinical-stage oncology company developing misetionamide — a first-in-class inhibitor of MYC, historically viewed as undruggable and [...]
Kessler Foundation and UPnRIDE Launch Research Initiative to Advance What’s Possible for People with Disabilities
24/09/2026
Research collaboration will further advance the capabilities, functionality, and real-world user experience of UPnRIDE’s upright mobility platform WEST ORANGE, N.J., Sept. 24, 2026 (GLOBE NEWSWIRE) -- UPnRIDE , the FDA- [...]
SK pharmteco Launches Catalyst Kit to Streamline Catalytic Reaction Development and Continuous Manufacturing Scale-Up
24/09/2026
New structured offering bridges the gap between catalyst screening, process optimization, and commercial-scale continuous flow manufacturing for RSMs, Intermediates, and APIs RANCHO CORDOVA, Calif., Sept. 24, 2026 ( [...]
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
24/09/2026
Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to support commercial execution and manufacturing expansion Company anticipates positive monthly operating cash flow by [...]
ŌURA Joins Workday Wellness, Giving Employers a New Way to Fund Oura Ring as a Flexible Benefit
24/09/2026
Employers can now fully fund, subsidize, or discount the world's leading smart ring for their workforce through Workday Benefits & Wellness SAN FRANCISCO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ŌURA, a leading health [...]
Anavex Stockholders Elect All of the Company’s Director Nominees at 2026 Annual Meeting
24/09/2026
NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system [...]
Hyperion DeFi Supports DoubleZero Edge in Launching the Fastest Commercially Available Hyperliquid Data Feeds
24/09/2026
DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced its first initiative to bring an infrastructure team from another blockchain into the [...]
Chiropractic Founders Day highlights nearly a century of care, paves way for National Upper Cervical Care Association's continued commitment to precise patient care in spinal health
24/09/2026
SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Each year, Chiropractic Founders Day is celebrated on Sept. 18, reminding the chiropractic community of the life-changing benefits it brings to millions worldwide. The date [...]
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
24/09/2026
DENVER, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com ) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has picked up fresh Wall Street coverage at a pivotal moment for its experimental brain-cancer pipeline. [...]
Ritedose Positioned to Support Hospitals with Reliable and Quality Albuterol Inhalation Solution, USP 0.5% (Albuterol Concentrate) Supply
24/09/2026
Ritedose expands albuterol inhalation solution production and strengthens its role as a trusted source for inhaled solutions The Company ramped up multiple albuterol inhalation solution strengths during national [...]
Easy Environmental Solutions Participates in International Roundtable at United Nations Headquarters During Climate Week NYC
24/09/2026
Company advances international relationships around localized fertilizer production, agricultural resilience, and commercial infrastructure development MANKATO, Minn. and NEW YORK, Sept. 24, 2026 (GLOBE NEWSWIRE) -- [...]
Coloplast A/S - Financial Calendar 2026/27
24/09/2026
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards, Investor Relations [...]
Adventure With a Purpose: A Race Against Blindness Unveils Adventure Package Fundraiser Valued at $350,000
24/09/2026
One winner will receive a luxury Entegra Super C motorhome, Polaris XPEDITION, trailer, and $100,000 cash GILBERT, Ariz., Sept. 24, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness has launched one of the largest [...]
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
24/09/2026
Biodesix-led tumor-informed and tumor-naïve programs draw on the company’s bioinformatics and diagnostics test development expertise LOUISVILLE, Colo., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a [...]
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
24/09/2026
Global Phase 3 study will evaluate efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease utilizing FVC as primary endpoint. Company expects to initiate study-related activities in the fourth [...]
MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
24/09/2026
LA JOLLA, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
24/09/2026
Topline durability data reinforce potential for single-dose miv-cel to free patients from life-long disease burden and chronic immunotherapies, further highlighting miv-cel’s differentiated construct Sustained clinical [...]

Pages